Loading organizations...
Ajinomoto Group Ventures is the corporate venture capital arm of Ajinomoto Co., Inc., investing at the frontiers of AminoScience. It strategically funds innovative companies across healthcare, ICT, food and wellness, and green technology, accelerating innovation by integrating external ventures with parent expertise and network. The firm aims to foster advancements aligned with its core scientific competencies.
Established by Ajinomoto Co., Inc., in December 2020, this venture arm originated from a strategic insight: expanding the parent company’s global well-being mission via AminoScience. Its formation aimed to identify external innovation, gather market intelligence, and cultivate partnerships, driving future group growth. This initiative reflects a proactive approach to evolving market needs and scientific breakthroughs.
Ajinomoto Group Ventures partners with founders whose innovations leverage parent company scientific resources for mutual impact. Collaborations emphasize enhancing portfolio performance and product quality. Its overarching vision advances the Ajinomoto Group’s mission: contributing to human well-being, society, and the planet through AminoScience, promoting "Eat Well, Live Well."
Ajinomoto Group Ventures has 2 tracked investments across 2 companies. The latest tracked deal is $4.0M Series A in Athian in November 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 19, 2025 | Athian | $4.0M Series A | — | Australian Agriculture Company, California Dairies, Curt Garner, Elanco Animal Health, Susanne Mathis Alig, Newtrient, Sustainable Futures, Tyson Ventures |
| May 1, 2025 | Somite | $47.0M Series A | Khosla Ventures | Boldstart Ventures, DST Global, Electric Capital, Founders Fund, HAN HUA, LUX Capital, Quiet Capital, Anthony Pompliano, Eric WU, Othman Laraki, Steve LEE, Fidji Simo, Martin Chavez, Chan Zuckerberg Initiative, Fusion Fund, Harpoon Ventures, Pitango HealthTech, SciFi VC, TechAviv |